Areca nut extracts attenuated interferon-γ and antigen-specific IgM production in BALB/c mice

Journal of Food and Drug Analysis

Volumn 19, Issue 3, 2011, Pages

  Wang, Chia Chi ^a,b   Deng, Ming Chung ^c   Jan, Tong Rong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Antigen specific; Areca nut; Interferon ; T cell

Indexed keywords

ARECA NUT EXTRACT; CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; OVALBUMIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BETEL NUT; CONTROLLED STUDY; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; SPLEEN CELL;

EID: 83455228658     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Nair, U., Bartsch, H. and Nair, J. 2004. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19: 251-262. (Pubitemid 39028948)
2. IARC. 2004. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks. Hum. 85: 1-334.
3. Tsai, J. F., Chuang, L. Y., Jeng, J. E. M., Ho, S., Hsieh, M. Y., Lin, Z. Y. and Wang, L. Y. 2001. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br. J. Cancer 84: 709-713. (Pubitemid 32239009)
4. Chang, L. Y., Wan, H. C., Lai, Y. L., Liu, T. Y. and Hung, S. L. 2006. Enhancing effects of areca nut extracts on the production of interleukin-6 and interleukin-8 by peripheral blood mononuclear cells. J. Periodontol. 77: 1969-1977.
5. Chang, M. C., Chiang, C. P., Lin, C. L., Lee, J. J., Hahn, L. J. and Jeng, J. H. 2005. Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol. 41: 757-775. (Pubitemid 41140017)
6. Rajendran, R., Sugathan, C. K., Remani, P., Ankathil, R. and Vijayakumar, T. 1986. Cell mediated and humoral immune responses in oral submucous fibrosis. Cancer 58: 2628-2631. (Pubitemid 17232920)
7. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8: 275-283. (Pubitemid 28188888)
8. Billiau, A. and Matthys, P. 2009. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 20: 97-113.
9. Chiang, C. P., Wu, H. Y., Liu, B. Y., Wang, J. T. and Kuo, M. Y. 2002. Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. Oral Oncol. 38: 56-63. (Pubitemid 34076573)
10. Haque, M. F., Harris, M., Meghji, S. and Speight, P. M. 1997. An immunohistochemical study of oral submucous fibrosis. J. Oral Pathol. Med. 26: 75-82. (Pubitemid 27157729)
11. Haque, M. F., Meghji, S., Khitab, U. and Harris, M. 2000. Oral submucous fibrosis patients have altered levels of cytokine production. J. Oral Pathol. Med. 29: 123-128. (Pubitemid 30156932)
12. Hung, S. L., Cheng, Y. Y., Peng, J. L., Chang, L. Y., Liu, T. Y. and Chen, Y. T. 2005. Inhibitory effects of areca nut extracts on phagocytosis of Actinobacillus actinomycetemcomitans ATCC 33384 by neutrophils. J. Periodontol. 76: 373-379.
13. Chang, M. C., Wu, H. L., Lee, J. J., Lee, P. H., Chang, H. H., Hahn, L. J., Lin, B. R., Chen, Y. J. and Jeng, J. H. 2004. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J. Biol. Chem. 279: 50676-50683.
14. Wang, C. C., Liu, T. Y., Wey, S. P., Wang, F. I. and Jan, T. R. 2007. Areca nut extract suppresses T-cell activation and interferon-gamma production via the induction of oxidative stress. Food Chem. Toxicol. 45: 1410-1418. (Pubitemid 47031386)
15. Chang, L. Y., Wan, H. C., Lai, Y. L., Kuo, Y. F., Liu, T. Y., Chen, Y. T. and Hung, S. L. 2009. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J. Periodontal. Res. 44: 175-183.
16. Wang, C. C., Lin, H. L., Wey, S. P. and Jan, T. R. 2011. Areca-nut extract modulates antigen-specific immunity and augments inflammation in ovalbumin-sensitized mice. Immunopharmacol. Immunotoxicol. 33: 315-322.
17. Liu, T. Y., Chen, C. L. and Chi, C. W. 1996. Oxidative damage to DNA induced by areca nut extract. Mutat. Res. 367: 25-31.
18. Lee, J. H., Chang, S. H., Park, Y. S., Her, E., Lee, H. Y., Park, J. W., Han, J. W., Kim, Y. M. and Choi, W. S. 2004. In-vitro and in-vivo anti-allergic actions of Arecae semen. J. Pharm. Pharmacol. 56: 927-933. (Pubitemid 38898630)
19. Mukherjee, A. and Giri, A. K. 1991. Sister chromatid exchange induced by pan masala'(a betel quid ingredient) in male mice in vivo. Food Chem. Toxicol. 29: 401-403.
20. Schroder, K., Hertzog, P. J., Ravasi, T. and Hume, D. A. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189. (Pubitemid 38174573)
21. Street, S. E. A., Trapani, J. A., MacGregor, D. and Smyth, M. J. 2002. Suppression of lymphoma and epithelial malignancies effected by interferon γ. J. Exp. Med. 196: 129-134. (Pubitemid 34747318)
22. Janeway, C. Travers, A., P., Walport, M. and Capra, J. D. 1996. Immunobiology: the immune system in health and disease. 6th ed. pp.26. Garland Pub. New York, U.S.A.
23. Haque, M. F., Harris, M., Meghji, S. and Barrett, A. W. 1998. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 10: 713-719. (Pubitemid 28457116)
24. Pillai, M. R., Balaram, P., Kannan, S., Sudha, L., Nalinakumari, K. R., Hareendran, N. K. and Nair, M. K. 1990. Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions. Oral Surg. Oral Med. Oral Pathol. 70: 458-461. (Pubitemid 20341661)
25. Heimdal, J. H., Aarstad, H. J., Klementsen, B. and Olofsson, J. 1998. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma. Acta. Otolaryngol. 118: 887-891. (Pubitemid 28545365)
26. Kim, R., Emi, M., Tanabe, K. and Arihiro, K. 2006. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 66: 5527-5536. (Pubitemid 43927099)
27. Balaram, P., Pillai, M. R. and Abraham, T. 1987. Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexes. J. Oral Pathol. 16: 389-391.
28. Chiang, C. P., Hsieh, R. P., Chen, T. H., Chang, Y. F., Liu, B. Y., Wang, J. T., Sun, A. and Kuo, M. Y. 2002. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J. Oral Pathol. Med. 31: 402-409. (Pubitemid 34973687)
29. Ranadive, K. J., Gothoskar, S. V., Rao, A. R., Tezabwalla, B. U. and Ambaye, R. Y. 1976. Experimental studies on betel nut and tobacco carcinogenicity. Int. J. Cancer 17: 469-476.
30. Dasgupta, R., Saha, I., Pal, S., Bhattacharyya, A., Sa, G., Nag, T. C., Das, T. and Maiti, B. R. 2006. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicology. 227: 94-104. (Pubitemid 44402852)
31. Selvan, R. S., Selvakumaran, M. and Rao, A. R. 1991. Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure. Immunopharmacol. Immunotoxicol. 13: 281-309.
32. Williamson, G. and Manach, C. 2005. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81: 243S-255S.
33. Miyake, M., Ide, K., Sasaki, K., Matsukura, Y., Shijima, K. and Fujiwara, D. 2008. Oral administration of highly oligomeric procyanidins of Jatoba reduces the severity of collagen-induced arthritis. Biosci. Biotechnol. Biochem. 72: 1781-1788.
34. Miyake, M., Sasaki, K., Ide, K., Matsukura, Y., Shijima, K. and Fujiwara, D. 2006. Highly oligomeric procyanidins ameliorate experimental autoimmune encephalomyelitis via suppression of Th1 immunity. J. Immunol. 176: 5797-5804.